Skip to content

KLRS KLRS Interest Expense

Interest Expense at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$12.9M+48.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$2.78M-6.9%
Regenxbio logo
RegenxbioRGNX
$8.71M+1.6%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$1.43M-22.7%
HRO
HarrowHROW
$5.5M-16.1%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Reported directly by KLRS in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's interest expense?
KLRS (KLRS) reported interest expense of $0 in Q1 2026.
How has KLRS's interest expense changed year-over-year?
KLRS's interest expense decreased by 100.0% year-over-year, from $1.44M to $0.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.